ANDA 72432, held by Quantum Pharmics. Diazepam.
As of Nov 14, 2026, ANDA 72432 (Q-Pam), held by Quantum Pharmics, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Q-Pam5MG ยท tablet;oral | Diazepam | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters